Showing results (551-560 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|August 16, 2005
Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UKLouis S Matza, Kristina Secnik, Sally Mannix, et al.Pharmacoeconomics|August 16, 2005
Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancySuzanne Polinder, Willem Jan Meerding, Job van Exel, et al.Pharmacoeconomics|February 3, 2007
The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: state-level evidence from 1997 to 2003Frank R LichtenbergPharmacoeconomics|February 3, 2007
Impact of Medicaid preferred drug lists on therapeutic adherenceDavid B Ridley, Kirsten J AxelsenPharmacoeconomics|February 3, 2007
Per-patient-per-month drug costs in Medicare Part D protected classesLisa Mucha, Neal A Masia, Kirsten J AxelsenPharmacoeconomics|January 26, 2007
A 'league table' of contingent valuation results for pharmaceutical interventions: a hard pill to swallow?Tracey H Sach, Richard D Smith, David K WhynesPharmacoeconomics|January 26, 2007
Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plansRalph P Insinga, Robbin F Itzler, James M PellissierPharmacoeconomics|January 26, 2007
Home-based medication review in older people: is it cost effective?Margaret Pacini, Richard D Smith, Edward C F Wilson, et al.Pharmacoeconomics|March 6, 2007
Cost effectiveness of an adherence-improving programme in hypertensive patientsDanielle E M Brunenberg, Gwenn E C Wetzels, Patricia J Nelemans, et al.Pharmacoeconomics|April 4, 2007
Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to dateIrina Cleemput, Fabienne DobbelsPageof 335